First in Human: who and what makes a cancer phase 1 trial and why are they so important?

Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi:10.17605/OSF.IO/KWHQF).

[img] Text (Enhanced PDF booklet)
245581.pdf - Published Version
Available under License Creative Commons Attribution.

3MB

Abstract

Bringing new cancer therapies into routine cancer care is a long and complex process. Phase 1 clinical trials assess new cancer treatments in people for the first time. It is a critical step in the pathway. The aim of this project is to make the world of a cancer Phase 1 trialist and the value they bring, understandable to others. From those interested in careers in cancer clinical trials to stakeholders and partners seeking to innovate across the cancer control continuum, through a deeper understanding and insight of those involved.

Item Type:Research Reports or Papers (Project Report)
Additional Information:Full Project resources are available from https://doi.org/10.17605/OSF.IO/KWHQF.
Status:Published
Glasgow Author(s) Enlighten ID:Keith, Professor Nicol and Hanna, Catherine and Evans, Professor Jeff and White, Dr Mark and Halsey, Professor Chris and Jones, Professor Robert and Welisch, Mr Gaston
Authors: Welisch, G., Twelves, C., Plummer, R., Evans, J., Danson, S., Symeonides, S., Halsey, C., Jones, R., Hanna, C., Gallagher, P., Walls, G., Taylor, K., Barnett, S., Forde, C., White, M., Williams, C., El Badri, S., Chipole, B.'e. D., and Keith, N.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Publisher:OSF
Published Online:09 June 2021
Copyright Holders:Copyright © 2021 The Authors
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record